+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Enhanced risk of steroid-resistant acute rejection following pretransplant steroid therapy in liver graft recipients



Enhanced risk of steroid-resistant acute rejection following pretransplant steroid therapy in liver graft recipients



Transplantation 60(10): 1104-1108



Most episodes of acute rejection will resolve after steroid therapy without detrimental consequences on the liver allograft. However, steroid-resistant acute rejection may induce irreversible lesions of the graft and is associated with an increased risk of chronic rejection. The aim of this study was to determine whether there were predictive factors for steroid-resistant acute rejection after liver transplantation. A total of 108 adult liver recipients with a follow-up of at least 2 years have been analyzed; sixty-two (57%) patients had at least one episode of acute rejection. The rates of steroid resistance were 35%, 52% and 83% after a first (n = 62), second (n = 25), or third (n = 7) episode of acute rejection, respectively. Steroid resistance of acute rejection was significantly associated with a past history of pretransplant steroid therapy (P = 0.004). High levels of ALT (P = 0.03) and serum bilirubin (P = 0.002) were also predictive of steroid-resistant acute rejection. Eight (7%) patients eventually developed chronic rejection. Predictive factors for chronic rejection included steroid-resistant acute rejection (P = 0.01), recurrent acute rejection (P = 0.03), and CMV infection (P = 0.01). In conclusion, this study suggests that pretransplant steroid administration or high levels of ALT and bilirubin in rejecting patients are risk factors for steroid resistance and should lead to aggressive antirejection therapy without delay.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008609147

Download citation: RISBibTeXText

PMID: 7482716

DOI: 10.1097/00007890-199511270-00008


Related references

OKT3 for recipients with steroid-resistant acute rejection after liver transplantation. Zhonghua Gan Zang Bing Za Zhi 15(11): 857-858, 2007

Risk factors of steroid resistant acute rejection and of chronic rejection after liver transplantation. Journal of Hepatology 16(SUPPL 1): S44-S45, 1992

Chronic Steroid Therapy Versus Steroid Withdrawal Plus Pulse Steroid Therapy for Rejection in Kidney Recipients with Basiliximab Therapy. American Journal of Transplantation 8(8): 1761-1762, 2008

Quantification Of Preformed Hla Antibodies By Flow Cytometry Identifies Patients At Risk For Steroid Resistant And Steroid Sensitive Liver Transplant Rejection. Transplantation 69(Supplement): S183-S184, 2000

High pretransplant serum levels of CXCL9 are associated with increased risk of acute rejection and graft failure in kidney graft recipients. Transplant International 23(5): 465-475, 2010

Long term tacrolimus rescue therapy is useful in kidney transplant recipients remaining on dialysis after steroid resistant acute rejection. Nephrology Dialysis Transplantation 12(9): A203, 1997

Steroid-resistant acute rejection following liver transplantation Risk factors and outcome. Hepatology 24(4 PART 2): 504A, 1996

Mycophenolate mofetil/Neoral/steroid vs Neoral/steroid therapy for prophylaxis of acute rejection in renal transplant recipients. Transplantation Proceedings 31(1-2): 1162-1164, 1999

Risk factors for steroid-resistant T-cell-mediated acute cellular rejection and their effect on kidney graft and patient outcome. Experimental and Clinical Transplantation 10(5): 446-453, 2013

Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection. Transplantation Proceedings 25(2): 1791-1793, 1993

Defective interleukin-1 receptor antagonist production is associated with resistance of acute liver graft rejection to steroid therapy. American Journal of Pathology 157(5): 1685-1692, 2000

Pretransplant Psychosocial Risk Factors May Not Predict Late Nonadherence and Graft Rejection in Adult Liver Transplant Recipients. Experimental and Clinical Transplantation 16(5): 533-540, 2017

Methotrexate for lung transplant recipients with steroid-resistant acute rejection. Journal of Heart and Lung Transplantation 15(11): 1130-1137, 1996

OKT3 treatment of steroid-resistant rejection in pediatric liver transplant recipients. Journal of Pediatric Gastroenterology and Nutrition 14(1): 86-91, 1992

Ursodeoxycholic acid prevents steroid resistant rejection in liver transplant recipients. Gastroenterology 108(4 SUPPL ): A1168, 1995